Document is current
Any future updates will be listed below
-
Authors
Arima, Mitsuru https://orcid.org/0000-0002-6081-8133
Inoue, Hirosuke
Misumi, Akiko
Tsukamoto, Shoko
Matsushita, Itsuka
Araki, Shunsuke
Ohta, Manami
Takahashi, Kazumasa
Imazato, Miyuki
Goto, Tomoko
Aoki, Yoshinori
Tagawa, Koshiro
Hirose, Masayuki
Fujita, Yuito
Yoshida, Noriko
Nakao, Shintaro
Kondo, Hiroyuki
Kusuhara, Koichi
Kimura, Kazuhiro
Hasegawa, Shunji
Ikeda, Yasuhiro
Kodama, Yuki
Moritake, Hiroshi
Ochiai, Masayuki
Ohga, Shouichi
Kishimoto, Junji
Todaka, Koji
Ieiri, Ichiro
Sonoda, Koh-Hei
-
Funding
Funding for this research was provided by:
the Japan Agency for Medical Research and Development (JP20ek0109458)
- License Information
-
More Information
Article History
Received: 27 October 2023
Accepted: 29 May 2024
First Online: 26 July 2024
Declarations
:
: M. Arima, S. Nakao and KH. Sonoda have received funding and drug substance from Kowa Co., Ltd. to conduct non-clinical studies to confirm the efficacy of ripasudil prior to conducting this clinical trial. S. Nakao and Kowa Co., Ltd. have disclosed the patent WO 2014/174747. No other potential conflicts of interest relevant to this article were reported.
